You are here

OncoGenex

OncoGenex Pharmaceuticals Management Discusses Q3 2012 Results - Earnings Call Transcript

Seeking Alpha

Fri, 11/9/12 - 11:10 am

OncoGenex Announces Initiation Of A Phase 3 Trial For Custirsen In Advanced Non-Small Cell Lung Cancer

Sacramento Bee, CA

Sat, 09/29/12 - 12:32 pm

non-small cell lung cancer

5 Pharmaceutical Companies With Insider Buying During August 14-16

Seeking Alpha

Sun, 08/19/12 - 11:30 am

Clovis Oncology

Furiex Pharmaceuticals

OncoGenex Pharmaceuticals, Inc. Reports Second Quarter and First-Half 2012 Financial Results and Reviews Clinical Development Highlights for Custirsen and OGX-427

PharmaLive

Sat, 08/4/12 - 12:45 pm

non-small cell lung cancer

3 Pharmaceutical Companies Seeing Insider Buys In Last 30 Days

Seeking Alpha

Tue, 06/26/12 - 01:46 pm

Durect Corporation

OncoGenex Pharmaceuticals, Inc. Announces Full Exercise of Overallotment Option by Underwriters

Pharmalive

Sat, 03/24/12 - 01:20 pm

OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering

Bradenton Herald, FL

Sat, 03/17/12 - 12:06 pm

Cancer-Fighting Biotech OncoGenex Rates a Buy

Minyanville

Fri, 03/16/12 - 11:40 am

OncoGenex Doubles Down on Prostate Cancer, As Competition Heats Up

Xconomy

Fri, 03/9/12 - 10:47 am

prostate cancer

4 Biotech Stocks Trading At A Steep Discount To Target Price

Seeking Alpha

Sun, 03/4/12 - 11:58 am

Corcept Therapeutics

Questcor Pharmaceuticals

Five Drugs That Own The Prostate Pipeline

Seeking Alpha

Tue, 11/8/11 - 11:00 am

prostate cancer

Teva Pharmaceuticals

Teva launches prostate cancer Phase III study

Globes, Israel

Sun, 10/3/10 - 12:18 pm

Teva Pharmaceuticals

prostate cancer

Five high-value biotech stocks to watch

Fierce Biotech

Tue, 07/27/10 - 12:28 pm

Array Biopharma

ASCO's Abstract Release Day: Preview

TheStreet.com

Wed, 05/19/10 - 07:09 pm

OncoGenex Pharmaceutical Downward Momentum Looks to Continue (OGXI)

Comtex Smartrend

Sat, 01/9/10 - 12:59 pm

Isis Gains from Teva-OncoGenex Deal

Yahoo/Zacks.com

Wed, 12/30/09 - 09:15 am

Isis Pharmaceuticals

Teva Pharmaceuticals

Isis Pharma receives US$ 10 mn from OncoGenex' license of OGX-O11 to Teva

Pharmabiz

Mon, 12/28/09 - 04:53 am

Isis Pharmaceuticals

Teva Pharmaceuticals

Partnering Activity Skyrockets as Biotechs Close Year-End Deals

BNET Pharma

Wed, 12/23/09 - 08:42 am

Teva Pharmaceuticals

Thallion Pharmaceuticals

LFB Biotechnologies

Durata Therapeutics

Pharma’s Holiday Shopping Spree

CNBC

Mon, 12/21/09 - 04:17 pm

Teva Pharmaceuticals

Seattle Genetics

Teva, OncoGenex sign drug development deal

Yahoo/AP

Mon, 12/21/09 - 09:58 am

Teva Pharmaceuticals

drug development

Pages